Acute effects of immediate and controlled-release levodopa on mood in Parkinson's disease: A double-blind study

Jaime Kulisevsky, Berta Pascual-Sedano, Manel Barbanoj, Alexandre Gironell, Javier Pagonabarraga, Carmen García-Sánchez

Research output: Contribution to journalArticleResearchpeer-review

60 Citations (Scopus)

Abstract

Mood fluctuations related to levodopa (LD) dosing are well-known psychiatric complications of Parkinson's disease (PD). No formal studies explored how affective response to LD relates to the type of motor response to oral LD (stable or wearing-off) and to different pharmacokinetic profiles of oral LD. We used an intrasubject randomized double-blind crossover design to study 14 patients (7 stable, 7 wearing-off) who were monitored for motor status, mood, anxiety, and plasma LD levels 1 hour before and 6 hours after an oral dose of immediate-release (IR) and controlled-release LD formulations. Analysis of the dose-response curves showed a significant interaction between the type of motor response and the type of LD. Only the wearing-off patients had a significant mood elevation, and this effect was only significant following challenge with IR LD. Motor status strongly correlated with LD plasma levels and anxiety but not with mood ratings. Mood changes in PD patients are related to the patient's type of motor response to oral LD and also to the kinetic profile of the LD formulation used for dopaminergic replacement. © 2006 Movement Disorder Society.
Original languageEnglish
Pages (from-to)62-67
JournalMovement Disorders
Volume22
Issue number1
DOIs
Publication statusPublished - 1 Jan 2007

Keywords

  • Anxiety
  • Dopamine
  • Levodopa
  • Mood
  • Parkinson's disease

Fingerprint

Dive into the research topics of 'Acute effects of immediate and controlled-release levodopa on mood in Parkinson's disease: A double-blind study'. Together they form a unique fingerprint.

Cite this